Comparison of once-daily versus twice-weekly terbinafine administration for the treatment of canine Malassezia dermatitis - a pilot study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Veterinary dermatology (Print)

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-3164.2012.01074.xPMID 22823935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of itraconazole pulses vs. continuous regimen in cutaneous sporotrichosis

  2011cited by this paper
• Comparison of two shampoos for the treatment of canine Malassezia dermatitis: a randomised controlled trial.

  2011cited by this paper
• The effect of nematode administration on canine atopic dermatitis.

  2011cited by this paper
• Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.

  2011cited by this paper
• Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US

  2011cited by this paper
• Terbinafine pharmacokinetics after single dose oral administration in the dog.

  2011cited by this paper
• A noninferiority clinical trial comparing fluconazole and ketoconazole in combination with cephalexin for the treatment of dogs with Malassezia dermatitis.

  2010cited by this paper
• Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs.

  2009cited by this paper
• Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs.

  2009cited by this paper
• Staphylococcus intermedius binding to immobilized fibrinogen, fibronectin and cytokeratin in vitro.

  2009cited by this paper
• Further validation of a pruritus severity scale for use in dogs.

  2009cited by this paper
• Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.

  2007cited by this paper
• Costs of pulse versus continuous terbinafine for onychomycosis.

  2007cited by this paper
• Planned equivalence or noninferiority trials versus unplanned noninferiority claims: are they equal?

  2006cited by this paper
• Cytochrome P450 and its role in veterinary drug interactions.

  2006cited by this paper
• Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.

  2005cited by this paper
• Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study.

  2005cited by this paper
• The biology of Malassezia organisms and their ability to induce immune responses and skin disease.

  2005cited by this paper
• Treatment of dermatophytosis in dogs and cats: review of published studies.

  2004cited by this paper
• Itraconazole: a treatment with pharmacokinetic foundations

  2004cited by this paper
• The effects of orally administered terbinafine on sebum composition

  2004cited by this paper
• Satisfaction with onychomycosis treatment. Pulse versus continuous dosing.

  2003cited by this paper
• Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds.

  2003cited by this paper
• A randomized controlled trial of misoprostol monotherapy for canine atopic dermatitis: effects on dermal cellularity and cutaneous tumour necrosis factor-alpha.

  2003cited by this paper
• Susceptibility testing of Malassezia pachydermatis using the urea broth microdilution method

  2002cited by this paper
• Comparison of pulse administration versus once daily administration of itraconazole for the treatment of Malassezia pachydermatis dermatitis and otitis in dogs.

  2002cited by this paper
• Comparison of two sampling techniques to assess quantity and distribution of Malassezia yeasts on the skin of Basset Hounds.

  2002cited by this paper
• Itraconazole pulse therapy for the treatment of Candida onychomycosis

  2001cited by this paper
• In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine

  2000cited by this paper
• Scavenging effects of terbinafine on free radicals in vitro

  1999cited by this paper
• Malassezia dermatitis and otitis.

  1999cited by this paper
• Design Issues in Noninferiority/Equivalence Trials

  1999cited by this paper
• Pharmacokinetics and pharmacology of terbinafine and itraconazole.

  1998cited by this paper
• Drug interactions with itraconazole, fluconazole, and terbinafine and their management.

  1998cited by this paper
• Terbinafine: an update.

  1997cited by this paper
• Factors associated with elevated cutaneous Malassezia pachydermatis populations in dogs with pruritic skin disease.

  1996cited by this paper
• Kinetics and spectrum of activity of oral antifungals: the therapeutic implications.

  1993cited by this paper
• Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat.

  1991cited by this paper
• Pharmacology of the allylamines.

  1990cited by this paper

• THE ROLE OF YEASTS IN ETIOLOGY OF CANINE OTITIS

  2024cites this paper
• A single-blind randomised study comparing the efficacy of fluconazole and itraconazole for the treatment of Malassezia dermatitis in client-owned dogs.

  2024cites this paper
• A safe bioadhesive system for topical delivery of combined antimicrobials in treatment of skin infections in veterinary medicine

  2023cites this paper
• Repeatability and reproducibility of microscopic examination of adhesive tape strip cytology slides for the quantification of Malassezia spp. in canine skin.

  2022cites this paper
• Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals

  2022cites this paper
• Yeast fungi of the genus Malassezia in dermatological diseases in animals

  2021cites this paper
• Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?

  2020cites this paper
• Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats Clinical Consensus Guidelines of the World Association for Veterinary Dermatology.

  2020cites this paper
• Malassezia Dermatitis

  2019cites this paper
• Malassezia ecology, pathophysiology, and treatment.

  2018cites this paper
• Canine Malassezia dermatitis.

  2017cites this paper
• Treatment of refractory sino‐nasal aspergillosis with posaconazole and terbinafine in 10 dogs

  2017cites this paper
• Evaluation of a single-administration ototopical treatment for canine otitis externa: a randomised trial

  2017cites this paper
• Diagnosis and treatment of dermatophytosis in dogs and cats.: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology

  2017cites this paper
• Successful Treatment of Canine Sporotrichosis with Terbinafine: Case Reports and Literature Review

  2017cites this paper
• Is topical treatment with Crystavet® an effective treatment of Malassezia overgrowth in dogs?

  2017influential citation
• Malassezia spp. in Feline Dermatology

  2016cites this paper
• Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)

  2015cites this paper
• Determining canine skin concentrations of terbinafine to guide the treatment of Malassezia dermatitis.

  2015cites this paper
• Therapy of Established Infections

  2015cites this paper
• E. Antifungal Agents

  2015cites this paper
• Clinical and mycological evaluation of an herbal antifungal formulation in canine Malassezia dermatitis.

  2014cites this paper
• Chapter 59 – Malassezia Infections

  2014cites this paper
• Dermatology in Dogs and Cats

  2013cites this paper